Showing results (181-190 of 651) with videos related to

Sort By:
Pageof 66
Cardiovascular Diabetology|August 24, 2023
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysisPeter Rossing, Stephen C Bain, Heidrun Bosch-Traberg, et al.
Diabetologia|April 2, 2016
Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuriaBernt Johan von Scholten, Henrik Reinhard, Tine W Hansen, et al.
Diabetologia|November 4, 2015
Cardiac (82)Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetesBernt J von Scholten, Philip Hasbak, Thomas E Christensen, et al.
Journal of Diabetes and Its Complications|December 21, 2024
Bone mineral density and the risk of kidney disease in patients with type 1 diabetesSabina Chaudhary Hauge, Henrik Øder Hjortkjær, Frederik Persson, et al.
Scientific Reports|November 10, 2019
Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetesNete Tofte, Tommi Suvitaival, Linda Ahonen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 9, 2017
Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertensionMorten Lindhardt, Frederik Persson, Christina Oxlund, et al.
Platelets|August 13, 2010
Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney functionMaria Lajer, Inge Tarnow, Alan D Michelson, et al.
Kidney International|May 11, 2005
Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathySteen Andersen, Frans A van Nieuwenhoven, Lise Tarnow, et al.
Stem Cell Research & Therapy|June 28, 2022
Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept studyJonas Askø Andersen, Anne Rasmussen, Marie Frimodt-Møller, et al.
Nephrology (Carlton, Vic.)|July 15, 2021
Sodium-glucose cotransporter 2 inhibitors for diabetes mellitus control after kidney transplantation: Review of the current evidenceMehmet Kanbay, Atalay Demiray, Baris Afsar, et al.
Pageof 66